Adverse Drug Reaction Quotes

Mania is a psychological state that can be brought about by medical procedures, adverse reactions to medications (notably steroids and SSRIs), drug abuse (such as cocaine and methamphetamines), trauma (physical or psychological), or persistent mental illness such as bipolar disorder. Once experienced, it is something that will never be forgotten.

Plants have long been, and still are, humanity’s primary medicines. They possess certain attributes that pharmaceuticals never will: 1) their chemistry is highly complex, too complex for resistance to occur — instead of a silver bullet (a single chemical), plants often contain hundreds to thousands of compounds; 2) plants have developed sophisticated responses to bacterial invasion over millions of years — the complex compounds within plants work in complex synergy with each other and are designed to deactivate and destroy invading pathogens through multiple mechanisms, many of which I discuss in this book; 3) plants are free; that is, for those who learn how to identify them where they grow, harvest them, and make medicine from them (even if you buy or grow them yourself, they are remarkably inexpensive); 4) anyone can use them for healing — it doesn’t take 14 years of schooling to learn how to use plants for your healing; 5) they are very safe — in spite of the unending hysteria in the media, properly used herbal medicines cause very few side effects of any sort in the people who use them, especially when compared to the millions who are harmed every year by pharmaceuticals (adverse drug reactions are the fourth leading cause of death in the United States, according to the Journal of the American Medical Association); and 6) they are ecologically sound. Plant medicines are a naturally renewable resource, and they don’t cause the severe kinds of environmental pollution that pharmaceuticals do — one of the factors that leads to resistance in microorganisms and severe diseases in people.

Thakur’s findings were not news to Ranbaxy’s top executives. Just ten months earlier, in October 2003, outside auditors started investigating Ranbaxy facilities worldwide. In this case, the audits had been ordered up by Ranbaxy itself. This was a common industry practice: drug companies often hired consultants to audit their facilities as a dry run to see how visible their problems were. If the consultants could find it, they reasoned, then most likely regulators could too. The fact-finding mission by Lachman Consultant Services left Ranbaxy officials under no illusion as to the extent of the company’s failings. At Ranbaxy’s Princeton, New Jersey, facility, auditors found that the company’s Patient Safety Department barely functioned and training was essentially “non-existent.” The staff had no written protocols for investigating patient complaints, which piled up in boxes, uncategorized and unreported. They had no clerical help for basic tasks like mailing out the patients’ samples for testing. “I don’t think there’s the same medicine in this medicine,” was a common refrain from patients. Even when there were investigations, they were so perfunctory and half-hearted that expiration dates were listed as “unknown,” even when they could easily have been found from a product’s lot number. An audit of Ranbaxy’s main U.S. manufacturing plant, Ohm Laboratories in New Jersey, found that the company, though required to report adverse events to the FDA, rarely did so. There was no system to capture patient complaints after hours, and no global medical officer to ensure that any potential negative consequences for patients were being monitored. The consultants from Lachman urged Ranbaxy to address these problems globally. Ranbaxy’s initial reaction to the findings was to question the number of hours, and the resulting invoice, that Lachman had sent for its work.

Back in 2016, when the Brooklyn incident occurred, AMB-FUBINACA was not yet banned. For this reason, sellers probably included it in their products as a replacement for a recently banned synthetic cannabinoid. The problem is that AMB-FUBINACA is considerably more potent than THC—and even more potent than JWH-018—meaning that far less of this substance is needed to produce effects, including unfavorable ones. Now that it’s banned, less well-known and likely more potent replacements will fill the void. That’s why the government’s knee-jerk response to ban any new psychoactive substance invariably leads to more unknown substances in the illicit market. This pattern has been repeatedly shown to jeopardize the health of people simply seeking to alter their consciousness. Note also that most users of synthetic cannabinoids consume these substances seeking a marijuana-like high and that serious adverse effects are rarely associated with adult marijuana use. Furthermore, an outbreak of negative health reactions to synthetic cannabinoids—like that which has been reported in several states, including Connecticut, Illinois, Maryland, and New York—is virtually unheard of in states where marijuana is legal. If you were serious about reducing problems associated with illicit synthetic cannabinoids, you would push for the expansion of legalized recreational marijuana. It’s utterly disheartening to know that regular, decent people’s health is unnecessarily placed at risk because of dishonest, callous leaders.

Considerable research has taken place to determine the potential adverse reactions from using the plant, and none have been found,

2 million North Americans are hospitalized because of adverse reactions to prescription drugs.2 The reason why drugs work in some people and cause bad reactions in others can usually be traced back to differences in genetic makeup.

Prescribing a drug results from clinical judgment based on a thorough assessment of the patient and the patient’s environment, the determination of medical and nursing diagnoses, a review of potential alternative therapies, and specific knowledge about the drug chosen and the disease process it is designed to treat. In general, the best therapy is the least invasive, least expensive, and least likely to cause adverse reactions. Frequently, the choice is to have nonpharmacological and pharmacological therapies working together.

However, because of the great marketing hype surrounding the SSRIs, one of them, Prozac, now has the distinguished honor of having more adverse effects submitted to the FDA than any other drug in history. More than 40,000 adverse reactions were reported in its first ten years on the market. No other drug even comes close (Breggin and Cohen 67).

Medical Warning: Talk to your doctor before beginning a John Locke series, as studies have shown them to be habit-forming and highly addictive. Do not read Locke if you suffer from high blood pressure or other heart-related issues, as readers often experience mood swings, increased pulses, elevated heart rates, and have reported unexpected shifts in body position that take them to the edge of their seats. Do not drive or use machinery while reading Locke novels. Locke novels are not for everyone, and may cause serious reactions including insomnia, night terrors, and uncontrollable, maniacal laughter. Tell your doctor right away if you have these, or if you experience unusual changes in your behavior including increased sexual urges, palpitations, or prolonged erections. Common side effects include confusion, hysteria, and trouble swallowing a given premise. Do not drink alcohol while reading Locke novels, though those with a history of drug or alcohol abuse may be more prone to understanding the material. Adverse reactions to Locke novels include nausea and vomiting, loss of appetite, severe itching, rectal bleeding, purple spots under the skin, and Jimmy Legs. In extreme cases, readers have reported laughing so hard they not only shit their pants, but other’s pants, as well. Upon completing a Locke series be prepared to experience symptoms of withdrawal, including fear, anger, extreme sadness, and moderate to severe depression. Ask your doctor today if John Locke novels are right for you!

The drug culture, as Dr. Lindsmith predicted back in 1967, has learned how to treat its own acid terrors, just as it earlier learned how to treat adverse reactions to pot. Quiet, sympathetic friends with consoling and reassuring voices, aided perhaps by a tranquilizer or vitamin B-3, will almost always abort such flip-outs.

The report acknowledges that, “The BMGF developed a model of chloroquine penetration into tissues for malaria.”69 BMGF’s unique dosing model for the studies deliberately overestimated the amount of HCQ that necessary to achieve adequate lung tissue concentrations. The WHO report confesses that, “This model is however not validated.” Gates’s deadly deception allowed FDA to wrongly declare that HCQ would be ineffective at safe levels. The minutes of that March 13, 2020 meeting suggest that BMGF knew the proper drug dosing and the need for early administration. Yet their same researchers then participated in deliberately providing a potentially lethal dose, failing to dose by weight, missing the early window during which treatment was known to be effective, and giving the drug to subjects who were already critically ill with comorbidities that made it more likely they would not tolerate the high dose. The Solidarity trial design also departed from standard protocols by collecting no safety data: only whether the patient died, or how many days they were hospitalized. Researchers collected no information on in-hospital complications. This strategy shielded the WHO from gathering information that could pin adverse reactions on the dose.

Adverse drug reactions are among the nation’s top four leading causes of death, after cancer and heart attacks.7,8 Dr. Fauci’s impressive longevity at NIAID is largely due to his enthusiasm for promoting this Pharma-centric agenda.

These records are packed with medical terms that help describe medical history of patients. For example, a doctor can avoid using certain medication on a particular patient if it is known from the patient’s medical records that the patient has had a history of adverse allergic reactions to those drugs.